Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Aerie Pharmaceuticals (AERI)

Aerie Pharmaceuticals (AERI)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 774,203
  • Shares Outstanding, K 46,893
  • Annual Sales, $ 83,140 K
  • Annual Income, $ -183,100 K
  • 60-Month Beta 0.72
  • Price/Sales 9.14
  • Price/Cash Flow N/A
  • Price/Book N/A
Trade AERI with:

Options Overview

Details
  • Implied Volatility 52.47%
  • Historical Volatility 31.98%
  • IV Percentile 1%
  • IV Rank 1.28%
  • IV High 175.76% on 09/02/20
  • IV Low 50.87% on 12/03/20
  • Put/Call Vol Ratio 0.00
  • Today's Volume 7
  • Volume Avg (30-Day) 100
  • Put/Call OI Ratio 0.74
  • Today's Open Interest 993
  • Open Int (30-Day) 1,877

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 11 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.66
  • Number of Estimates 6
  • High Estimate -0.61
  • Low Estimate -0.77
  • Prior Year -0.83
  • Growth Rate Est. (year over year) +20.48%

Price Performance

See More
Period Period Low Period High Performance
1-Month
14.91 +10.73%
on 06/09/21
18.54 -10.95%
on 05/21/21
-1.07 (-6.09%)
since 05/18/21
3-Month
14.91 +10.73%
on 06/09/21
20.13 -17.98%
on 03/19/21
-3.10 (-15.81%)
since 03/18/21
52-Week
9.01 +83.24%
on 10/21/20
21.30 -22.49%
on 03/15/21
+1.15 (+7.49%)
since 06/18/20

Most Recent Stories

More News
Aerie Pharmaceuticals Completes Enrollment of its first Phase 3 Clinical Trial of Netarsudil Ophthalmic Solution in Japan

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 16.51 (+1.85%)
Aerie Pharmaceuticals to Participate in the Raymond James Human Health Innovation Conference

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 16.51 (+1.85%)
Glaucoma Therapeutics Market Size, Share, Trends, Analysis and Forecast 2027

The Global is estimated to value over USD 10.1 billion by 2027 end at a CAGR of over 6% during the forecast period 2020 to 2027.

AERI : 16.51 (+1.85%)
AGN : 193.02 (+0.02%)
ITEK : 3.04 (-5.00%)
NVS : 93.01 (-1.21%)
PFE : 38.81 (-1.70%)
TEVA : 10.12 (-2.69%)
VRX.TO : 30.80 (-3.33%)
Why Is Aerie (AERI) Down 7.7% Since Last Earnings Report?

Aerie (AERI) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.

AERI : 16.51 (+1.85%)
Aerie's (AERI) Q1 Loss Wider Than Expected, Revenues Miss

Aerie (AERI) incurs a wider loss in the first quarter of 2021 and sales miss expectations.

PFE : 38.81 (-1.70%)
RGEN : 197.34 (-1.15%)
CORT : 22.50 (-2.13%)
AERI : 16.51 (+1.85%)
Aerie Pharmaceuticals to Participate in the Bank of America Securities 2021 Healthcare Conference

Aerie Pharmaceuticals, Inc. (NASDAQ: AERI), an ophthalmic pharmaceutical company focused on the discovery, development and commercialization of first-in-class therapies for the treatment of patients with...

AERI : 16.51 (+1.85%)
Aerie Pharmaceuticals (AERI) Reports Q1 Loss, Misses Revenue Estimates

Aerie (AERI) delivered earnings and revenue surprises of -4.35% and -1.64%, respectively, for the quarter ended March 2021. Do the numbers hold clues to what lies ahead for the stock?

AERI : 16.51 (+1.85%)
Aerie: Q1 Earnings Snapshot

NORTH CAROLINA, N.C. (AP) _ Aerie Pharmaceuticals Inc. (AERI) on Wednesday reported a loss of $42 million in its first quarter.

AERI : 16.51 (+1.85%)
Aerie Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Business Update

--First Quarter 2021 Net Revenues of $23.0 Million Increased 12.9% over First Quarter 2020

AERI : 16.51 (+1.85%)
Jazz Pharma (JAZZ) Q1 Earnings Beat, Sales Miss, Stock Down

Jazz Pharmaceuticals (JAZZ) reports mixed first-quarter 2021 results as earnings beat estimates while sales miss the same. Shares down

JAZZ : 177.28 (-0.26%)
CORT : 22.50 (-2.13%)
AERI : 16.51 (+1.85%)
GWPH : 218.96 (-0.15%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 8% Buy with a Weakest short term outlook on maintaining the current direction.

See More Share

Business Summary

Aerie Pharmaceuticals, Inc. is a clinical-stage pharmaceutical company. It is focused on the discovery, development and commercialization of therapies for the treatment of patients with glaucoma and other diseases of the eye. The Company's lead `Dual- Action` product and `Triple-Action` products are...

See More

Key Turning Points

3rd Resistance Point 17.52
2nd Resistance Point 17.04
1st Resistance Point 16.78
Last Price 16.51
1st Support Level 16.04
2nd Support Level 15.56
3rd Support Level 15.30

See More

52-Week High 21.30
Fibonacci 61.8% 16.61
Last Price 16.51
Fibonacci 50% 15.15
Fibonacci 38.2% 13.70
52-Week Low 9.01

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar